Kaiser seen as biggest earner as HMO profits soared in 2003














The good times rolled on for the nation's HMOs in 2003, according to Weiss Ratings. The industry nearly doubled its profits, earning $10.2 billion, an 86 percent increase from the $5.5 billion it earned in 2002.

Kaiser Foundation Health Plan was the big winner, reporting a $1.1 billion increase in earnings. That is about one-fifth of the industry's net profit improvement.

Kaiser's increase "is a result of regulatory changes that required the company to consolidate its year-end financial statements for all entities owned, including hospitals and provider groups," says Weiss.

Of course, not all players in health care can be expected to celebrate HMOs' good fortune. "The industry's soaring profits continue to irk both consumers and businesses who are shouldering skyrocketing health care costs without any perceived improvements in benefits," says Melissa Gannon, Weiss vice president. "We may soon see the next wave of consumer backlash forcing HMOs to evolve their cost structures."

Five biggest HMO earners (in millions of dollars)

SOURCE: WEISS RATINGS

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.